(Q37068830)

18 August 2017

1 reference

title

Clinical studies in spinal cord injury: moving towards successful trials (English)

1 reference

18 August 2017

S Knafo

1

1 reference

18 August 2017

D Choi

series ordinal

2

1 reference

18 August 2017

publication date

1 February 2008

1 reference

British Journal of Neurosurgery

18 August 2017

published in

1 reference

18 August 2017

volume

22

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

3-12

1 reference

Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Peripheral nerve injury fails to induce growth of lesioned ascending dorsal column axons into spinal cord scar tissue expressing the axon repellent Semaphorin3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Report of international clinical trials workshop on spinal cord injury February 20-21, 2004, Vancouver, Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Strategies to promote neural repair and regeneration after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Effect of 4-aminopyridine on gait in ambulatory spinal cord injuries: a double-blind, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Randomized trial of 4-aminopyridine in patients with chronic incomplete spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Phase 2 trial of sustained-release fampridine in chronic spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Fetal cell grafts into resection and contusion/compression injuries of the rat and cat spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Obliteration of a posttraumatic spinal cord cyst with solid human embryonic spinal cord grafts: first clinical attempt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Peripheral nerve grafts and aFGF restore partial hindlimb function in adult paraplegic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Spinal cord repair with acidic fibroblast growth factor as a treatment for a patient with chronic paraplegia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Specialized neuroglial arrangement may explain the capacity of vomeronasal axons to reinnervate central neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Transplantation of nasal olfactory tissue promotes partial recovery in paraplegic adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Peripherally-derived olfactory ensheathing cells do not promote primary afferent regeneration following dorsal root injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Olfactory ensheathing cell grafts have minimal influence on regeneration at the dorsal root entry zone following rhizotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Autologous olfactory ensheathing cell transplantation in human spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Hematopoietic stem cell and marrow stromal cell for spinal cord injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Transplanted hematopoietic stem cells from bone marrow differentiate into neural lineage cells and promote functional recovery after spinal cord injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Cellular transplantation strategies for spinal cord injury and translational neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Nogo in the injured spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Nogo-66 receptor antagonist peptide promotes axonal regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Therapeutic interventions after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Chondroitinase ABC promotes functional recovery after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

21 January 2018

Controversy in China.

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Rapid recovery of segmental neurological function in a tetraplegic patient following transplantation of fetal olfactory bulb-derived cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

Clinical trials in spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701593595

10.1080/02688690701593595

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference